SpineGuard Strengthens Its Intellectual Property With a New Patent Granted in the USA
18 Oktober 2021 - 8:30AM
Business Wire
- Perfecting the ‘real time’ characteristic of
the DSG technology
- Protection until 2035
Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company
that deploys its DSG (Dynamic Surgical Guidance) sensing technology
to secure and streamline the placement of bone implants, announced
today the grant of a new patent in the United States, following
grants in China, Japan, Mexico, France, Israel, Russia and
Singapore. This patent discloses certain characteristics of the DSG
technology that optimize its real time implementation.
Stéphane Bette, Deputy CEO and cofounder of SpineGuard,
said: “Since its foundation, SpineGuard has been developing,
deploying and fine-tuning its tissue electrical conductivity local
measurement technology for securing and streamlining the placement
of implants in bone, manually or with robotic assistance, while
decreasing the dangerous systematic reliance on X-ray imaging. Our
intellectual property portfolio keeps expanding and the validated
invention perfects our technology and affirms its uniqueness in the
long term, a key asset in the context of our strategic discussions
with potential industry partners. The grant of this major patent in
the United States coincides with the ongoing strengthening of our
commercial organization in the largest market of our sector.”
Since its inception, SpineGuard develops and maintains a
significant IP portfolio now reaching 15 patent families totaling
78 patents and applications as well as 3 trademarks, in the major
geographies such as Europe, USA and China.
SpineGuard is focused on the following priorities while striving
to remain close to breakeven:
- Boost commercial activities with the launch of the DSG-Connect
visual interface.
- Implement DSG technology in ortho-robotics through the
deployment of AI algorithms, new scientific evidence, and
additional patents.
- Intensify the collaboration with ConfiDent ABC for the dental
application and co-develop a new generation of products embedding
the DSG technology.
- Affirm the company’s technological shift and sign strategic
partnerships in particular for the use of DSG technology in the
robotic field.
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 85,000 surgical
procedures worldwide. Seventeen studies published in peer-reviewed
scientific journals have demonstrated the multiple benefits DSG®
offers to patients, surgeons, surgical staff and hospitals.
Building on these solid fundamentals and several strategic
partnerships, SpineGuard has expanded its technology platform in a
disruptive innovation: the « smart » pedicle screw launched late
2017 and is broadening the scope of applications in dental
implantology and surgical robotics. DSG® was co-invented by Maurice
Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem,
Biomedical Engineer.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211017005011/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel: +33 1 45
18 45 19 p.jerome@spineguard.com SpineGuard Manuel Lanfossi
CFO Tel: +33 1 45 18 45 19 m.lanfossi@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin / Pierre Laurent Tel.: +33 1 44 71 94 94
spineguard@newcap.eu
Spineguard (EU:ALSGD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Spineguard (EU:ALSGD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024